Travaux scientifiques

Doç. Dr. Mehmet Orkun Sevik

57 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. Resolution of cystoid macular edema with topical carbonic anhydrase inhibitor in a patient with retinal dystrophy associated with Cohen syndrome

    Ophthalmic Genetics, 2021

    DOI 10.1080/13816810.2021.1925928 PMID 33974487 2 citations (Europe PMC) Source : ORCID

  2. The effect of COVID-19 pandemic restrictions on neovascular AMD patients treated with treat-and-extend protocol

    International Ophthalmology, 2021

    DOI 10.1007/s10792-021-01854-6 PMID 33864577 30 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  3. 'Transcorneal Electrical Stimulation Therapy May Have A Stabilization Effect on Multifocal Electroretinography for Patients with Retinitis Pigmentosa'.

    Retina (Philadelphia, Pa.), 2021

    DOI 10.1097/iae.0000000000003386 PMID 34923514 6 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  4. Clinical outcomes with a low add multifocal and an extended depth of focus intraocular lenses both implanted with mini-monovision.

    Eye (London, England), 2021

    DOI 10.1038/s41433-021-01600-3 PMID 34117383 16 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  5. Immediate changes in blood pressure during intravitreal anti-VEGF agents' applications in exudative age-related macular degeneration patients

    International Ophthalmology, 2020

    DOI 10.1007/s10792-020-01431-3 PMID 32495059 3 citations (Europe PMC) Source : ORCID

  6. Comparison of reading performance with low add bifocal and extended depth of focus intraocular lenses implanted with mini-monovision

    International Ophthalmology, 2020

    DOI 10.1007/s10792-020-01584-1 PMID 32914276 13 citations (Europe PMC) Source : ORCID

  7. Topical Treatment of Persistent Epithelial Defects with a Matrix Regenerating Agent

    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2018

    DOI 10.1089/jop.2018.0025 PMID 30312119 7 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID